These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 20335266

  • 1. Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.
    Delos SE, La B, Gilmartin A, White JM.
    J Virol; 2010 Jun; 84(11):5687-94. PubMed ID: 20335266
    [Abstract] [Full Text] [Related]

  • 2. Structural characterization of a fusion glycoprotein from a retrovirus that undergoes a hybrid 2-step entry mechanism.
    Aydin H, Smrke BM, Lee JE.
    FASEB J; 2013 Dec; 27(12):5059-71. PubMed ID: 24036886
    [Abstract] [Full Text] [Related]

  • 3. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
    Matsuyama S, Delos SE, White JM.
    J Virol; 2004 Aug; 78(15):8201-9. PubMed ID: 15254191
    [Abstract] [Full Text] [Related]

  • 4. Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.
    Delos SE, White JM.
    J Virol; 2000 Oct; 74(20):9738-41. PubMed ID: 11000247
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
    Earp LJ, Delos SE, Netter RC, Bates P, White JM.
    J Virol; 2003 Mar; 77(5):3058-66. PubMed ID: 12584331
    [Abstract] [Full Text] [Related]

  • 7. Alpharetrovirus envelope-receptor interactions.
    Barnard RJ, Young JA.
    Curr Top Microbiol Immunol; 2003 Mar; 281():107-36. PubMed ID: 12932076
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
    Melikyan GB, Barnard RJ, Markosyan RM, Young JA, Cohen FS.
    J Virol; 2004 Apr; 78(7):3753-62. PubMed ID: 15016895
    [Abstract] [Full Text] [Related]

  • 11. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
    Melder DC, Yin X, Delos SE, Federspiel MJ.
    J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
    Melder DC, Pike GM, VanBrocklin MW, Federspiel MJ.
    J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
    [Abstract] [Full Text] [Related]

  • 14. Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection.
    Rong L, Edinger A, Bates P.
    J Virol; 1997 May; 71(5):3458-65. PubMed ID: 9094617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.
    J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.